Medical Communications

Our approach is for each writer to take full responsibility for a project from an initial briefing through to final delivery, collaborating with the client team and authors to produce an accurate and incisive document that enhances the client's reputation.

Specialists in anti-infectives

Acceptance rate of 98% over two decades of publications experience, slide kits (for symposia, CME or training),
in-house poster production.

Communications Expertise


Peer-reviewed journals (original scientific research, primary and secondary clinical research, systematic reviews)

Congress Abstracts & Posters

Scientific /clinical study results – content development and in-house graphic design and printing

Slide Kits

Symposia oral presentations, internal training materials

Regulatory Documents

Investigator brochures, clinical study reports, common technical document safety reports


Writers are graduates or postgraduates.

Senior writers are ISMPP Certified Medical Publication Professionals™

Every writer has

4 years

minimum industry experience

Senior writers' experience ranges from
14 years

up to 40 years

Time at Micron

9 years

Average time of being in a writing position at Micron
with a range of 3 to 20 years

Our professional qualifications and ethics

Our medical writing adheres to Good Publication Practice (GPP) and the recommendations of the International Committee of Medical Journal Editors (ICMJE).
Our position statement describes how we ensure that all of our work is of the highest scientific integrity and is consistent with best practice.

Our Client Relationships

We have a collaborative partnership approach to working with our clients.
We believe this is the most efficient route towards achieving the client’s goals. Here’s what a few of our clients have said about us…

Therapeutic areas

Our team’s detailed knowledge of anti-infectives is complemented by our writers’ experience of many different clinical indications and areas of scientific research, summarised in the table below.

Therapy Area Clinical Indications and Scientific Research
Anti-infectives Community-acquired pneumonia | Healthcare-associated pneumonia | Ventilator-associated pneumonia | Acute bacterial skin and skin structure infections | Intra-abdominal infections | Urinary tract infections | Hepatitis
Cardiology Interventional cardiology | Chronic heart failure | Hypertension | Angina
Endocrinology Diabetes (type I & II) | Obesity | Cushings syndrome | Pituitary gland tumours | Female ovarian function
Gastroenterology Inflammatory bowel disease (IBD) | Irritable bowel syndrome (IBS)
Haematology Sickle cell anaemia | Acute/chronic clotting factor deficiency | Acute/chronic thrombocytopaenia
Immunology Auto-immune diseases (rheumatoid arthritis, immune thrombocytopenic purpura [ITP]) | Inflammation signalling pathways
Nephrology Chronic kidney disease (CKD) | Acute kidney failure | Dialysis | Secondary hyperparathyroidism (SHPT)
Neurology and central nervous system (CNS) Alzheimer’s | Parkinson’s | Dementia and psychiatry | Degenerative diseases | Pain control and palliative care
Oncology Breast cancer | Lung cancer | Chemotherapy-induced neutropenia | Intracellular signalling pathways as targets for novel treatments
Ophthalmology Wet age-related macular degeneration (wAMD) | Macular oedema
Orthopaedics Tendonitis
Rheumatology Osteoporosis | Rheumatoid arthritis
Case studies

Case Study Duration
Comprehensive publications programme for an anti-infectives portfolio 4 years view
Worldwide surveillance study Ongoing view
Product overview for regulatory submission N/A view